Resolutions of the Aspo Annual Shareholders’ Meeting
Decisions of general meeting
April 6, 2022 at 1:15 p.m.
Resolutions of the Aspo Annual Shareholders’ Meeting
The Annual Shareholders' Meeting of Aspo Plc was held today on April 6, 2022 in Helsinki. For the purpose of preventing the spread of the coronavirus pandemic, the Annual Shareholders’ Meeting was held without shareholders’ and their proxy representatives’ presence at the venue of the meeting. The Annual Shareholders' Meeting of Aspo Plc approved the company's and consolidated financial statements 2021 and discharged the members of the Board of Directors and the CEO from the liability. The Annual Shareholders’ meeting approved the payment of a dividend totalling EUR 0.23 per share. The record date for the dividend will be April 8, 2022 and the payment date will be April 19, 2022.
Furthermore, the Annual Shareholders’ Meeting authorized the Board of Directors to decide, at a later date, on the distribution of an aggregate maximum of EUR 0.22 per share as dividend and/or as equity repayment from the invested unrestricted equity reserve. The authorization is valid until the Annual Shareholders’ Meeting in 2023. The Board of Directors will decide in its meeting agreed to be held on November 2, 2022, of the second dividend distribution and/or equity repayment, an aggregate maximum of EUR 0.22 per share, which would be paid in November 2022 to shareholders who are registered in the shareholders’ register maintained by Euroclear Finland Oy on the record date.
The Annual Shareholders’ Meeting also adopted the Company’s Remuneration Report and Remuneration Policy, as proposed by the Board of Directors.
Board of Directors and Auditor
The meeting confirmed the number of Board members at seven. Patricia Allam, Mammu Kaario, Mikael Laine, Salla Pöyry, Tatu Vehmas and Heikki Westerlund were re-elected to the Board of Directors. Tapio Kolunsarka was elected as a new member of the Board. At the Board's organizing meeting held after the Annual Shareholders' Meeting, Heikki Westerlund was elected as Chairman of the Board and Mammu Kaario as Vice Chairman. At the meeting the Board decided to appoint Heikki Westerlund as Chairman of the Human Resources and Remuneration Committee, and Tapio Kolunsarka, Salla Pöyry and Tatu Vehmas as committee members. At the meeting the Board also decided to appoint Mammu Kaario as Chairman of the Audit Committee, and Patricia Allam, Mikael Laine and Tatu Vehmas as committee members.
The Authorized Public Accountant firm Deloitte Oy was re-elected as company auditor. Deloitte Oy has announced that Jukka Vattulainen, APA, will act as the auditor in charge. The remuneration shall be paid to the auditor according to the accepted invoice.
Remuneration of the members of the Board of Directors and the Committees
The Annual Shareholders' Meeting approved that EUR 5,400 be paid per month for the Chairman of the Board of Directors, EUR 4,050 per month for the Vice Chairman and EUR 2,700 per month for the other members of the Board of Directors.
The Annual Shareholders' Meeting approved that the following remuneration be paid to the members of the Audit Committee as well as to the members of the Remuneration Committee. The shareholders approved that EUR 1,050 per meeting be paid for the Chairman of the committee and EUR 700 per meeting be paid for the committee members. If the Chairman of the committee is also the Chairman or the Vice Chairman of the Board of Directors, the fee paid to the Chairman of the committee is the same as that paid to members of the committee.
Board members having a full-time position in an Aspo Group company are not paid a fee.
Authorization of the Board of Directors to decide on the acquisition of treasury shares
As proposed by the Board of Directors, the Annual Shareholders’ Meeting authorized the Board of Directors to decide on the acquisition of no more than 500,000 of the treasury shares. The authorization includes the right to accept treasury shares as a pledge. The authorization is valid until the Annual Shareholders’ Meeting in 2023 but not more than 18 months from the approval at the Shareholders’ Meeting.
Authorization of the Board of Directors to decide on a share issue of treasury shares
As proposed by the Board of Directors, the Annual Shareholders´ Meeting authorized the Board of Directors to decide on a share issue, through one or several installments, to be executed by conveying treasury shares. An aggregate maximum amount of 900,000 shares may be conveyed based on the authorization. The authorization is valid until the Annual Shareholders’ Meeting in 2023 but not more than 18 months from the approval at the Shareholders’ Meeting.
Authorization of the Board of Directors to decide on a share issue of new shares
As proposed by the Board of Directors, the Annual Shareholders’ Meeting authorized the Board of Directors to decide on a share issue of new shares against payment. The authorization includes the right of the Board of Directors to decide on all of the other terms and conditions of the conveyance and thus also includes the right to decide on a directed share issue, in deviation from the shareholders’ pre-emptive right, if a compelling financial reason exists for the company to do so. The total number of new shares to be offered for subscription may not exceed 1,500,000. The authorization is valid until the Annual Shareholders’ Meeting in 2023 but not more than 18 months from the approval at the Shareholders’ Meeting.
Authorization of the Board of Directors to decide on charitable contributions
As proposed by the Board of Directors, the Annual Shareholders’ Meeting authorized the Board of Directors to decide on contributions in the total maximum amount of EUR 100,000 for charitable or similar purposes, and to decide on the recipients, purposes and other terms of the contributions. The authorization is valid until the Annual Shareholders’ Meeting in 2023.
Rolf Jansson, CEO, +358 400 600 264, firstname.lastname@example.org
Aspo creates value by owning and developing business operations sustainably and in the long term. Our companies aim to be market leaders in their sectors. They are responsible for their own operations, customer relationships and the development of these aiming to be forerunners in sustainability. Aspo supports its businesses profitability and growth with the right capabilities. Aspo Group has businesses in 18 different countries, and it employs a total of approximately 960 professionals
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Sinch resolves on an in-kind issue of shares to the sellers of Pathwire26.5.2022 10:00:00 CEST | Press release
Stockholm, Sweden – 26 May 2022 – Sinch AB (publ) (the “Company” or “Sinch”), a global leader in cloud communications for mobile customer engagement, today announces that the board of directors, in accordance with what was communicated on 7 December 2021, has resolved on an in-kind share issue of 25.5 million shares to the sellers of Pathwire. On 30 September 2021, Sinch disclosed that it had entered into an agreement to acquire Pathwire and the acquisition was completed on 7 December 2021. In addition to the cash consideration, Sinch shall issue an aggregate of 51 million shares in the Company as consideration to the sellers, of which the first 25.5 million shares were issued in February 2022. The board of directors has today resolved to issue the remaining 25.5 million of these shares. The payment of the shares consists of a receivable, under the agreement for the acquisition of Pathwire, against two of the company’s subsidiaries. The contributed receivable amounts to the remaining U
Sinch beslutar om apportemission av aktier till säljarna av Pathwire26.5.2022 10:00:00 CEST | Pressemelding
Stockholm, Sverige – 26 maj 2022 – Sinch AB (publ) (”Bolaget” eller ”Sinch”), en ledande global leverantör av molntjänster för kundinteraktion via mobilen, meddelar idag att styrelsen, i enlighet med vad som har kommunicerats i pressmeddelande den 7 december 2021, har beslutat om apportemission av 25,5 miljoner aktier till säljarna av Pathwire. Sinch offentliggjorde den 30 september 2021 att avtal om att förvärva Pathwire hade ingåtts och förvärvet slutfördes den 7 december 2021. I tillägg till den kontanta köpeskillingen ska Sinch emittera sammanlagt 51 miljoner nya aktier i Sinch som del av vederlaget till säljarna, varav de första 25,5 miljoner aktierna emitterades i februari 2022. Styrelsen har idag beslutat att emittera de resterande 25,5 miljoner aktierna. Betalningen har skett genom apport av en fordran enligt avtalet avseende förvärvet av Pathwire, på två av Bolagets dotterbolag, om de återstående 500 miljoner USD (den initiala delen av fordran om 500 miljoner USD tillfördes i
Nokia and Taiwan Mobile strengthen partnership with energy-efficient 5G coverage expansion deal26.5.2022 07:00:00 CEST | Press release
Press Release Nokia and Taiwan Mobile strengthen partnership with energy-efficient 5G coverage expansion deal New deal will see delivery of enhanced country-wide 5G coverage; Nokia’s energy-efficient AirScale portfolio will support TWM’s sustainability commitments Expansion of 5G Standalone Core includes slicing and low-latency edge cloud for enterprise, and Voice over New Radio (VoNR) 26 May 2022 Espoo, Finland – Nokia today announced that it has been selected by Taiwan Mobile (TWM) in an expansion deal to enhance the operator’s 5G coverage across the country. Under the deal, Nokia will provide its latest energy-efficient AirScale portfolio supporting TWM’s commitments to RE100 and reaching 100 percent renewable energy by 2040. It will also provide a smooth network evolution path following the completion of the proposed merger with Taiwan Star. Nokia will provide equipment from its AirScale portfolio, including base stations and massive MIMO antennas to boost network performance and c
Mandalay Resources Corporation Announces the Results of Its Annual General Meeting of Shareholders25.5.2022 23:32:49 CEST | Press release
TORONTO, May 25, 2022 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation ("Mandalay" or the "Company") (TSX: MND, OTCQB: MNDJF) is pleased to announce the results of its Annual General Meeting of Shareholders (the “Meeting”) held today virtually. All the resolutions presented at the Meeting were approved by the shareholders, with the votes cast by proxy representing 67.63% of the total shares outstanding as of the record date. Election of Directors The number of directors was fixed at seven members and each of the seven nominees listed in the Company’s Management Information Circular dated April 14, 2022, were re-elected to the Company’s Board of Directors. Abraham Jonker remains the lead independent director and Bradford Mills continues as Chair. Results of the votes cast by proxy are set out below. ResolutionVotes Cast by Proxy For% ForVotes Cast by Proxy Withheld% WithheldBradford A. Mills61,552,12099.95329,1930.047Abraham Jonker61,551,31399.95130,0000.049Amy Freedman61,547,53899.94
Galapagos to showcase commitment to rheumatoid arthritis care at the upcoming European League Against Rheumatism congress25.5.2022 22:01:00 CEST | Press release
Celebrating EULAR’s 75thanniversary with focus on a new era of rheumatoid arthritis care Mechelen, Belgium;25 May 2022, 22.01CET;Galapagos NV (Euronext & Nasdaq: GLPG) will present 11 abstracts at the European League Against Rheumatism (EULAR) congress 2022, 01-04 June, taking place in Copenhagen, Denmark. The broad range of abstracts include trial data analyses supporting the efficacy and safety profile of filgotinib andreal-world clinical data around alignment of prescribing between physicians and rheumatoid arthritis (RA) patients. Galapagos is also hosting a hybrid symposium: “Evolving patient care in RA: Can JAK inhibitors meet patient and physician expectations for RA treatment?”, which will include a discussion focused on aligning physician and patient treatment goals, looking at what is meant by ‘comprehensive care’ and how to ensure that people living with RA are part of treatment and care goal setting. A meet-the-expert session, “Patient-centred care in RA: cutting through th